Your browser doesn't support javascript.
Transmission of SARS-CoV-2 in standardised first few X cases and household transmission investigations: A systematic review and meta-analysis.
Lewis, Hannah C; Marcato, Adrian J; Meagher, Niamh; Valenciano, Marta; Villanueva-Cabezas, Juan-Pablo; Spirkoska, Violeta; Fielding, James E; Karahalios, Amalia; Subissi, Lorenzo; Nardone, Anthony; Cheng, Brianna; Rajatonirina, Soatiana; Okeibunor, Joseph; Aly, Eman A; Barakat, Amal; Jorgensen, Pernille; Azim, Tasnim; Wijesinghe, Pushpa R; Le, Linh-Vi; Rodriguez, Angel; Vicari, Andrea; Van Kerkhove, Maria D; McVernon, Jodie; Pebody, Richard; Price, David J; Bergeri, Isabel; Al Ariqi, Lubna; Alemu, Mikias A; Alvi, Yasir; Bukusi, Elizabeth A; Chung, Pui Shan; Dambadarjaa, Davaalkham; Das, Ayan K; Dub, Timothée; Dulacha, Diba; Ebrahim, Faiqa; González-Duarte, Maritza A; Guruge, Dinuka; Heraud, Jean-Michel; Heredia-Melo, Damaris C; Herman-Roloff, Amy; Herring, Belinda L; Inbanathan, Francis Y; Islam, Farzana; Jeewandara, Kamal Chandima; Kant, Shashi; Khan, Wasiq; Lako, Richard; Leite, Juliana; Malavige, Gathsaurie Neelika.
  • Lewis HC; World Health Organization Geneva Switzerland.
  • Marcato AJ; World Health Organization, Regional Office for Africa Brazzaville Republic of Congo.
  • Meagher N; Department of Infectious Diseases The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity Melbourne Australia.
  • Valenciano M; Department of Infectious Diseases The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity Melbourne Australia.
  • Villanueva-Cabezas JP; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health The University of Melbourne Melbourne Australia.
  • Spirkoska V; World Health Organization Geneva Switzerland.
  • Fielding JE; Epiconcept Paris France.
  • Karahalios A; Department of Infectious Diseases The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity Melbourne Australia.
  • Subissi L; The Nossal Institute for Global Health The University of Melbourne Melbourne Australia.
  • Nardone A; Department of Infectious Diseases The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity Melbourne Australia.
  • Cheng B; Victorian Infectious Diseases Reference Laboratory Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity Melbourne Australia.
  • Rajatonirina S; Department of Infectious Diseases The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity Melbourne Australia.
  • Okeibunor J; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health The University of Melbourne Melbourne Australia.
  • Aly EA; Victorian Infectious Diseases Reference Laboratory Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity Melbourne Australia.
  • Barakat A; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health The University of Melbourne Melbourne Australia.
  • Jorgensen P; World Health Organization Geneva Switzerland.
  • Azim T; World Health Organization Geneva Switzerland.
  • Wijesinghe PR; Epiconcept Paris France.
  • Le LV; World Health Organization Geneva Switzerland.
  • Rodriguez A; School of Population and Global Health McGill University Montreal Quebec Canada.
  • Vicari A; World Health Organization, Regional Office for Africa Brazzaville Republic of Congo.
  • Van Kerkhove MD; World Health Organization, Regional Office for Africa Brazzaville Republic of Congo.
  • McVernon J; World Health Organization, Regional Office for the Eastern Mediterranean Cairo Egypt.
  • Pebody R; World Health Organization, Regional Office for the Eastern Mediterranean Cairo Egypt.
  • Price DJ; World Health Organization Regional Office for Europe Copenhagen Denmark.
  • Bergeri I; World Health Organization, Regional Office for South-East Asia New Delhi India.
  • Al Ariqi L; World Health Organization, Regional Office for the Western Pacific Manila Philippines.
  • Alemu MA; World Health Organization, Regional Office for the Americas (Pan American Health Organization) Washington DC USA.
  • Alvi Y; World Health Organization, Regional Office for the Americas (Pan American Health Organization) Washington DC USA.
  • Bukusi EA; World Health Organization Geneva Switzerland.
  • Chung PS; Department of Infectious Diseases The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity Melbourne Australia.
  • Dambadarjaa D; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health The University of Melbourne Melbourne Australia.
  • Das AK; Murdoch Children's Research Institute Melbourne Australia.
  • Dub T; World Health Organization Regional Office for Europe Copenhagen Denmark.
  • Dulacha D; Department of Infectious Diseases The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity Melbourne Australia.
  • Ebrahim F; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health The University of Melbourne Melbourne Australia.
  • González-Duarte MA; World Health Organization Geneva Switzerland.
  • Heraud JM; World Health Organization, Regional Office for the Eastern Mediterranean Cairo Egypt.
  • Heredia-Melo DC; Ethiopian Public Health Institute Addis Ababa Ethiopia.
  • Herman-Roloff A; Department of Community Medicine Hamdard Institute of Medical Sciences and Research New Delhi India.
  • Herring BL; Kenya Medical Research Institute Nairobi Kenya.
  • Inbanathan FY; World Health Organization, Regional Office for the Western Pacific Manila Philippines.
  • Islam F; School of Public Health Mongolian National University of Medical Sciences Ulaanbaatar Mongolia.
  • Jeewandara KC; Department of Microbiology Hamdard Institute of Medical Science and Research New Delhi India.
  • Kant S; Hakeem Abdul Hameed Centenary Hospital New Delhi India.
  • Khan W; Department of Health Security Finnish Institute for Health and Welfare Helsinki Finland.
  • Lako R; WHO Country Office Juba South Sudan.
  • Leite J; World Health Organization Country Office Addis Ababa Ethiopia.
  • Malavige GN; National Institute of Health Bogotá Colombia.
Influenza Other Respir Viruses ; 16(5): 803-819, 2022 09.
Article in English | MEDLINE | ID: covidwho-1895988
ABSTRACT
We aimed to estimate the household secondary infection attack rate (hSAR) of SARS-CoV-2 in investigations aligned with the WHO Unity Studies Household Transmission Investigations (HHTI) protocol. We conducted a systematic review and meta-analysis according to PRISMA 2020 guidelines. We searched Medline, Embase, Web of Science, Scopus and medRxiv/bioRxiv for "Unity-aligned" First Few X cases (FFX) and HHTIs published 1 December 2019 to 26 July 2021. Standardised early results were shared by WHO Unity Studies collaborators (to 1 October 2021). We used a bespoke tool to assess investigation methodological quality. Values for hSAR and 95% confidence intervals (CIs) were extracted or calculated from crude data. Heterogeneity was assessed by visually inspecting overlap of CIs on forest plots and quantified in meta-analyses. Of 9988 records retrieved, 80 articles (64 from databases; 16 provided by Unity Studies collaborators) were retained in the systematic review; 62 were included in the primary meta-analysis. hSAR point estimates ranged from 2% to 90% (95% prediction interval 3%-71%; I 2 = 99.7%); I 2 values remained >99% in subgroup analyses, indicating high, unexplained heterogeneity and leading to a decision not to report pooled hSAR estimates. FFX and HHTI remain critical epidemiological tools for early and ongoing characterisation of novel infectious pathogens. The large, unexplained variance in hSAR estimates emphasises the need to further support standardisation in planning, conduct and analysis, and for clear and comprehensive reporting of FFX and HHTIs in time and place, to guide evidence-based pandemic preparedness and response efforts for SARS-CoV-2, influenza and future novel respiratory viruses.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza, Human / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Influenza Other Respir Viruses Journal subject: Virology Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza, Human / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Influenza Other Respir Viruses Journal subject: Virology Year: 2022 Document Type: Article